Tailor an Options Trading Strategy to Fit Your Needs
This guide will help you identify and execute an options trading strategy that fits your specific needs and risk profile.

Take your trading to the next level with the Options Strategy Guide.
Download your FREE Options Strategy Guide Today.

AURA Insider Trading (Aura Biosciences)

Insider Ownership Percentage: 5.00%
Insider Buying (Last 12 Months): $430,200.00
Insider Selling (Last 12 Months): $0.00

Aura Biosciences Insider Trading History Chart

This chart shows the insider buying and selling history at Aura Biosciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Aura Biosciences Share Price & Price History

Current Price: $18.99
Price Change: Price Increase of +1.55 (8.89%)
As of 08/12/2022 01:00 AM ET

This chart shows the closing price history over time for AURA up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
A One Stop Shop for Everything Futures Trading
Whether you're looking to learn the basics of futures or are a seasoned vet looking to hone your trading skills, our Technical Analysis Guide has everything you need to succeed in today's futures markets!
Download your FREE Technical Analysis Trading Guide Today.

Aura Biosciences Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/13/2022David Michael JohnsonDirectorBuy20,000$13.99$279,800.0030,000View SEC Filing Icon  
6/10/2022David Michael JohnsonDirectorBuy10,000$15.04$150,400.0010,000View SEC Filing Icon  
See Full Table
A One Stop Shop for Everything Futures Trading
Whether you're looking to learn the basics of futures or are a seasoned vet looking to hone your trading skills, our Technical Analysis Guide has everything you need to succeed in today's futures markets!
Download your FREE Technical Analysis Trading Guide Today.

SEC Filings (Institutional Ownership Changes) for Aura Biosciences (NASDAQ:AURA)

51.69% of Aura Biosciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at AURA by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Aura Biosciences Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/13/2022American International Group Inc.8,577$0.12M0.0%+208.3%0.029%Search for SEC Filing on Google Icon
8/12/2022Northern Trust Corp132,692$1.88M0.0%+188.0%0.453%Search for SEC Filing on Google Icon
8/12/2022FMR LLC603,471$8.55M0.0%+22.1%2.062%Search for SEC Filing on Google Icon
8/12/2022Rhumbline Advisers20,713$0.29M0.0%N/A0.071%Search for SEC Filing on Google Icon
8/11/2022UBS Group AG16,320$0.23M0.0%+2,064.5%0.056%Search for SEC Filing on Google Icon
8/11/2022JPMorgan Chase & Co.9,798$0.14M0.0%+272.8%0.033%Search for SEC Filing on Google Icon
8/3/2022Regency Capital Management Inc. DE254,622$3.61M3.9%N/A0.870%Search for SEC Filing on Google Icon
6/7/2022Bank of America Corp DE11,857$0.26M0.0%+53.5%0.041%Search for SEC Filing on Google Icon
5/16/2022California State Teachers Retirement System2,358$52K0.0%-21.8%0.008%Search for SEC Filing on Google Icon
5/16/2022State Street Corp84,982$1.87M0.0%+80.1%0.291%Search for SEC Filing on Google Icon
5/13/2022Charles Schwab Investment Management Inc.15,379$0.34M0.0%+30.1%0.053%Search for SEC Filing on Google Icon
5/13/2022Nantahala Capital Management LLC301,990$6.64M0.3%+204.6%1.034%Search for SEC Filing on Google Icon
5/13/2022Vanguard Group Inc.228,633$5.03M0.0%+1.0%0.782%Search for SEC Filing on Google Icon
5/12/2022BlackRock Inc.275,027$6.05M0.0%+15.2%0.941%Search for SEC Filing on Google Icon
5/11/2022Bank of New York Mellon Corp14,496$0.32M0.0%N/A0.050%Search for SEC Filing on Google Icon
5/11/2022JPMorgan Chase & Co.2,628$58K0.0%-60.2%0.009%Search for SEC Filing on Google Icon
5/10/2022Decheng Capital Management III Cayman LLC210,000$4.62M1.4%N/A0.719%Search for SEC Filing on Google Icon
5/5/2022New York State Common Retirement Fund6,252$0.14M0.0%+134.3%0.021%Search for SEC Filing on Google Icon
2/16/2022Matrix Capital Management Company LP4,112,870$69.84M0.8%N/A14.080%Search for SEC Filing on Google Icon
2/15/2022Adage Capital Partners GP L.L.C.1,255,480$21.32M0.0%N/A4.298%Search for SEC Filing on Google Icon
2/14/2022Citadel Advisors LLC2,315,102$37.32M0.0%N/A7.925%Search for SEC Filing on Google Icon
2/11/2022Allianz Asset Management GmbH55,145$0.94M0.0%N/A0.189%Search for SEC Filing on Google Icon
2/8/2022Northern Trust Corp45,875$0.78M0.0%N/A0.157%Search for SEC Filing on Google Icon
2/3/2022Medicxi Ventures Management Jersey Ltd3,039,892$51.62M12.9%N/A10.407%Search for SEC Filing on Google Icon
2/2/2022New York State Common Retirement Fund2,668$45K0.0%N/A0.009%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Aura Biosciences logo
Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develops AU-011 in additional ocular oncology indications, including choroidal metastases. The company was incorporated in 2009 and is headquartered in Cambridge, Massachusetts.
Read More on Aura Biosciences

Today's Range

Now: $18.99
Low: $18.25
High: $19.37

50 Day Range

MA: $14.51
Low: $12.37
High: $19.08

52 Week Range

Now: $18.99
Low: $11.98
High: $26.16

Volume

52,625 shs

Average Volume

43,539 shs

Market Capitalization

$555.65 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Aura Biosciences?

Aura Biosciences' top insider investors include:
  1. David Michael Johnson (Director)
Learn More about top insider investors at Aura Biosciences.

Who are the major institutional investors of Aura Biosciences?

Aura Biosciences' top institutional investors include:
  1. FMR LLC — 2.06%
  2. Regency Capital Management Inc. DE — 0.87%
  3. Northern Trust Corp — 0.45%
  4. Rhumbline Advisers — 0.07%
  5. UBS Group AG — 0.06%
  6. JPMorgan Chase & Co. — 0.03%
Learn More about top institutional investors of Aura Biosciences stock.

Which institutional investors are buying Aura Biosciences stock?

Within the previous quarter, AURA stock was bought by institutional investors including:
  1. Regency Capital Management Inc. DE
  2. FMR LLC
  3. Northern Trust Corp
  4. Rhumbline Advisers
  5. UBS Group AG
  6. JPMorgan Chase & Co.
  7. American International Group Inc.
A One Stop Shop for Everything Futures Trading
Whether you're looking to learn the basics of futures or are a seasoned vet looking to hone your trading skills, our Technical Analysis Guide has everything you need to succeed in today's futures markets!
Download your FREE Technical Analysis Trading Guide Today.